The World Health Organization has issued its first-ever hepatitis B guidelines that outline how to determine who needs treatment, what medicines to use and how to monitor patients long-term. The ...
The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...
In a pair of articles published in Lancet Gastroenterology & Hepatology, scientists lay out the case for why we should expand treatment recommendations for people with hepatitis B. Subscribe to our ...
Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...
HBsAg, hepatitis B surface antigen; ALT, alanine aminotransferase; ULN, the upper limit of normal; TDF, tenofovir disoproxil fumarate; HBV, hepatitis B virus; anti-HBs, hepatitis B surface antibody.
Future Virology. 2012;7(10):955-972. Four studies in children investigated the combination of lamivudine with interferon-α in treatment-naive children with elevated aminotransferases. [32–35] The ...
Viral diseases called hepatitis B and C primarily target the liver and often incubate quietly for decades before any symptoms appear. Eradicating hepatitis and avoiding liver complications, including ...
Hepatitis B testing can show whether you have a current or past HBV infection and whether you have antibodies from a hepatitis B vaccine. Hepatitis B is a viral infection caused by the hepatitis B ...